We investigated whether enhanced APN expression provides therapeutic benefit against AngII-induced AAA by injecting AdGFP or AdAPN into AngII-infused hyperlipidemic LDLR−/− 11, 18. The gene discussed is AGT; the disease is triple-A syndrome.